Europe`s First Lung Transplant on a Coronavirus Patient

May 26, 2020 - Last week, the Department of Surgery of MedUni Vienna/Vienna General Hospital carried out an urgent and highly complex lung transplant on a 45-year-old woman from Austria, who had developed severe respiratory failure as a result of Covid-19. The team led by Walter Klepetko, Head of the Department of Surgery and of the Division of Thoracic Surgery, successfully replaced the patient's lungs, which had been damaged beyond repair, with new donor lungs. This is the first time in Europe that a Covid-19 patient has been given a lung transplant in an otherwise hopeless situation.

"We are very satisfied with the patient's condition, given the extremely difficult initial circumstances. Only a few days after the procedure, the patient is well on the way to recovery," says Klepetko.

Ventilation had become practically impossible

From being completely healthy, the patient contracted coronavirus about eight weeks ago and went on to suffer complete respiratory failure, so that even artificial ventilation was no longer possible and she could only be kept alive by means of a circulation pump (ECMO – extracorporeal membrane oxygenation).

Last week, she was therefore flown in an Austrian Army Black Hawk helicopter to Vienna General Hospital/MedUni Vienna and taken to the Intensive Care Unit. At this point, a PCR test showed that coronavirus particles were still present but these were no longer judged to be infectious, as was ultimately confirmed by a negative viral culture, Klepetko emphasises.

Since the woman's other organs were still working as normally as possible but there was no chance of her lungs recovering, the team of Viennese experts took the decision to perform an urgent transplant. The donor lungs were allocated by and in coordination with the independent Euotransplant Organisation in Leiden (Netherlands) on the basis of the objective urgency criteria and flown in from a neighbouring country.

"The transplant itself took place under extremely difficult circumstances, since the patient did not have an adequate blood platelet count and, since antibodies were also present, these first had to be removed by means of immune apheresis to prevent her from rejecting the organ," explains the surgeon. "Even transportation of the lungs and preparation for the operation took place under difficult conditions, especially because of the necessary Covid-19 logistics and the associated protective measures, which all had to be observed. In cases such of this, the key to success is smooth and effective collaboration between the various professional groups, such as anaesthesia, surgery, intensive care medicine, infectiology and many others."

Globally respected lung transplant programme

"The fact that we were able to deal with this extremely complex and challenging case as well as we did, with excellent teamwork, is down to the experience that has been built up at Vienna General Hospital/MedUni Vienna over the years with many complex cases from abroad. Only a few centres in the world have such extensive experience," Klepetko points out. Since it started in 1989, the Vienna Lung Transplantation Programme at the Division of Thoracic Surgery of the Department of Surgery of MedUni Vienna/Vienna General Hospital has become one of the best in the world. With around 100 lung transplants being performed every year, it is one of the largest programmes in the world, alongside those in Toronto, Cleveland and Hanover.

Please direct enquiries to:

Mag. Johannes Angerer

Communication and Public Relations Manager

Tel.: 01/ 40 160-11501

E-mail: pr@meduniwien.ac.at

Medical University of Vienna

Medical University Vienna (MedUni Vienna) is one of the most traditional medical education and research facilities in Europe. With almost 8,000 students, it is currently the largest medical training centre in the German-speaking countries. With 5,500 employees, 26 departments and three clinical institutes, 12 medical theory centres and numerous highly specialised laboratories, it is also one of Europe's leading research establishments in the biomedical sector.